Methylphenidate hydrochloride (MPH) improves AttentionDeficit/ Hyperactivity Disorder (ADHD) symptoms, but it is not clear to improve the quality of life (QoL) in patients with ADHD simultaneously. In the previous studies, Atomoxetine (ATX)demonstrated to improve ADHD symptoms, but the relationship between QoL and ADHD symptoms was unclear. We reported a case of decreasing self-esteem score after administration of OROS-MPH to a 10-years-old boywith ADHD. Using ADHD-RS-IV score before and 3 months after MPH medication, his mother and the home room teacher did the evaluation and behavioral improvement was confirmed. They both agreed his behaviors that we actually observed in the examination room had been improved. We have simultaneously examined total QoL andscores of each six domains in the Japanese version of Kid-KINDLR (age 7-13) questionnaire before and 3 months after the administration of MPH medication by himself and his mother. Although evaluation by the parent was unchanged between two evaluations in this case, his own evaluation of QoL fell down after medication. The domains contributed in a major way to the total QoL decrement were self-esteem and family. We surmised the self-discernment was explained that relationship between him and others could have become
very clear by taking osmotic release oral system -Methylphenidate hydrochloride (OROS-MPH).
A Case of Decreasing Self-esteem Score after Administration of OROS-MPH to a 10-years-old Boy with ADHD
Last date updated on September, 2020